- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Practical Adherence to Topical Treatment of Psoriasis from the Point of View of Drug Usage :
-
- NAKAHARA Takeshi
- Department of Dermatology, Graduate School of Medical Sciences, Kyushu University
-
- TAKEUCHI Satoshi
- Department of Dermatology, Graduate School of Medical Sciences, Kyushu University
-
- KOKUBA Hisashi
- Department of Dermatology, Graduate School of Medical Sciences, Kyushu University
-
- SATOMURA Akiko
- Department of Dermatology, Graduate School of Medical Sciences, Kyushu University
-
- MITOMA Chikage
- Department of Dermatology, Graduate School of Medical Sciences, Kyushu University
-
- MOROI Yoichi
- Department of Dermatology, Graduate School of Medical Sciences, Kyushu University
-
- FURUE Masutaka
- Department of Dermatology, Graduate School of Medical Sciences, Kyushu University
Bibliographic Information
- Other Title
-
- 尋常性乾癬外用療法における薬剤使用量からみた外用アドヒアランスの実際
- 治療 尋常性乾癬外用療法における薬剤使用量からみた外用アドヒアランスの実際 : 0.05%ベタメタゾン酪酸エステルプロピオン酸エステル軟膏単独と50μg/gカルシポトリオール軟膏併用療法の比較検討
- チリョウ ジンジョウセイカンセンガイヨウ リョウホウ ニ オケル ヤクザイ シヨウリョウ カラ ミタ ガイヨウ アドヒアランス ノ ジッサイ : 0.05%ベタメタゾンラクサン エステルプロピオンサン エステル ナンコウ タンドク ト 50mg/gカルシポトリオール ナンコウ ヘイヨウ リョウホウ ノ ヒカク ケントウ
- Comparison of Combination of Betamethasone Butyrate Propionate and Calcipotriol with Betamethasone Butyrate Propionate Alone
- ―― 0.05%ベタメタゾン酪酸エステルプロピオン酸エステル軟膏単独と 50 μg/gカルシポトリオール軟膏併用療法の比較検討――
Search this article
Description
We compared the clinical effects, patients' QOL, and adherence of psoriasis treatment with a) a combination of betamethasone butyrate propionate and calcipotriol, and b) betamethasone butyrate propionate alone. Although the clinical effects of both treatment showed equivalent efficacy, the usage of betamethasone butyrate propionate was a little smaller in combination treatment, and only the combination treatment improved patients' QOL. Surprisingly, the percentage of drug usage in the volume of prescription were very low. This study indicates that combination treatment of betamethasone butyrate propionate and calcipotriol is useful in terms of dose reduction of corticosteroid, and improvement of adherence in topical treatment might increase the clinical effects.
Journal
-
- The Nishinihon Journal of Dermatology
-
The Nishinihon Journal of Dermatology 75 (6), 534-539, 2013
Western Division of Japanese Dermatological Association
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390001204301053952
-
- NII Article ID
- 130004831845
-
- NII Book ID
- AN00183881
-
- ISSN
- 18804047
- 03869784
-
- NDL BIB ID
- 025069891
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- CiNii Articles
- OpenAIRE
-
- Abstract License Flag
- Disallowed